2-(3-Ethoxy-5-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

3-(4-tert-Butyl-phenyl)-propionic acid, 97.0%, 5g

3,5-Difluoroiodobenzene, 98.0%, 5g

(R)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 5g

DL-treonina, mínimo 98 %, para bioquímica, 500 g, envase de plástico.

ETHYL 4-AZAINDOLE-6-CARBOXYLATE, 95.0%, 100mg

2-Bromo-4,5-dichloro-1H-imidazole, 98.0%, 5g

[S(R)]-N-[(S)-[3,5-Di-tert-butyl-4-methoxyphenyl][(3-benzyloxy-2-(dicyclohexylphosphino)phenyl)methyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

2,2-dimethyl-3-(1-phenylhydrazin-1-yl)propan-1-ol, 95.0%, 250mg

3,5-Diphenyl-pyridin-2-ylamine, 95.0%, 1g

5-Chloro-3-methyl-4-nitro-1H-pyrazole, 95.0%, 1g

5,6-Dimethyl-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

2-(3-Nitrophenyl)-4-phenylthiazole, 1g